Systematic analysis of several tissue extracts for peptide components follo
wed by bioactivity studies leads to formulation of the concept of "tissue-s
pecific peptide pools" According to that concept the endogenous proteolysis
of proteins with well-established functions, such as hemoglobin, actin, an
d cellular enzymes in tissues leads to formation of the sets (or pools) of
bioactive peptides. The sets are tissue-specific on one hand and conservati
ve in a given tissue at normal conditions on the other. The content and the
composition of pool components are sensitive both to pathologies linked wi
th alterations of tissue metabolism and to prolonged physiological changes.
In vivo formation of fragments of functional proteins includes several con
secutive proteolytic stages inside the cells and further release of bioacti
ve compounds into the surrounding medium. The effects of pool components ta
ke place predominantly at tissue and cellular levels, their effects being r
elated to stimulation or inhibition of cell growth, induction of cell diffe
rentiation, and death. The above-mentioned features lead to the proposal th
at the main in vivo function of components of tissue-specific peptides is m
aintenance of tissue homeostasis, i.e., the normal ratio of functional, div
iding, differentiating, and dying cells of tissues. Components of tissue-sp
ecific peptide pools display several features distinguishing them from "cla
ssical" peptide hormones and neuromediators. Summarizing, a novel peptiderg
ic regulatory system is considered.